Contribution of MRGPRX2-mediated basophil degranulation in patients with chronic spontaneous urticaria refractory to omalizumab treatment (Extended Methods and Results)

This repository contains extended methods, results, an extended figure, and an extended table supporting the research letter entitled “Contribution of MRGPRX2-mediated basophil degranulation in patients with chronic spontaneous urticaria refractory to omalizumab treatment,” submitted to Clinical & Experimental Allergy. The materials provide detailed experimental procedures, additional results, and supporting data related to MRGPRX2-mediated degranulation in patients with chronic spontaneous urticaria.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-03
DOI
https://doi.org/10.5281/zenodo.23900821
Primary Topic
Urticaria and Related Conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contribution of MRGPRX2-mediated basophil degranulation in patients with chronic spontaneous urticaria refractory to omalizumab treatment (Extended Methods and Results)

Min Sook Ryu, Jieun Seo, Eun-mi Yang, Young-Min Ye et al.
Zenodo (CERN European Organization for Nuclear Research)
Urticaria and Related Conditions
article

Contribution of MRGPRX2-mediated basophil degranulation in patients with chronic spontaneous urticaria refractory to omalizumab treatment (Extended Methods and Results)

Min Sook Ryu, Jieun Seo, Eun-mi Yang, Young-Min Ye, You-Seob Shin, Hyunmi Kim, Hae-Sim Park
article en

Abstract

This repository contains extended methods, results, an extended figure, and an extended table supporting the research letter entitled “Contribution of MRGPRX2-mediated basophil degranulation in patients with chronic spontaneous urticaria refractory to omalizumab treatment,” submitted to Clinical & Experimental Allergy. The materials provide detailed experimental procedures, additional results, and supporting data related to MRGPRX2-mediated degranulation in patients with chronic spontaneous urticaria.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 13%
Urticaria and Related Conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon